Safety and efficacy of psychopharmacological agents used to treat the psychiatric sequelae of common neurological disorders

Carmina G. Bernardo, Vivek Singh, Peter M. Thompson

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background: Psychiatric disorders and symptoms, ranging from mood dysregulation to delirium, are commonly observed in many neurological disorders. These manifestations complicate the illness and worsen prognosis. Pharmacological treatment options may be limited by the primary neurological illness and side effects. Objective: This paper aims to review the safety and efficacy of pharmacological agents used to treat psychiatric manifestations of several common neurological conditions, including Alzheimer's disease (AD), post-stroke, traumatic brain injury (TBI) and epilepsy. Methods: Systematic review of the Medline database for articles published between 2000 and 2007 was done to retrieve relevant articles. Results: The paucity of controlled data on the pharmacological treatments of psychiatric manifestations of neurological conditions makes recommendations difficult. Conclusion: When secondary depression, mania, anxiety, and delirium remain after treatment of the underlying condition, clinical experience and the limited research indicates that judicious pharmacological interventions may effectively treat mood dysregulation, delirium and agitation.

Original languageEnglish (US)
Pages (from-to)435-445
Number of pages11
JournalExpert Opinion on Drug Safety
Volume7
Issue number4
DOIs
StatePublished - Jul 2008

Fingerprint

Nervous System Diseases
Psychiatry
Delirium
Pharmacology
Safety
Neurologic Manifestations
Bipolar Disorder
Epilepsy
Alzheimer Disease
Anxiety
Stroke
Databases
Depression
Research

Keywords

  • Aggression
  • Alzheimer's disease
  • Antidepressants
  • Anxiety
  • Atypical antipsychotics
  • Benzodiazepines
  • Carbamazepine
  • Delirium
  • Depression
  • Epilepsy
  • Mania
  • Post-stroke
  • Psychosis
  • Seizures
  • Traumatic brain injury
  • Valproate

ASJC Scopus subject areas

  • Pharmacology

Cite this

Safety and efficacy of psychopharmacological agents used to treat the psychiatric sequelae of common neurological disorders. / Bernardo, Carmina G.; Singh, Vivek; Thompson, Peter M.

In: Expert Opinion on Drug Safety, Vol. 7, No. 4, 07.2008, p. 435-445.

Research output: Contribution to journalArticle

@article{0d8f4837bd5246f486dd092cf59995b7,
title = "Safety and efficacy of psychopharmacological agents used to treat the psychiatric sequelae of common neurological disorders",
abstract = "Background: Psychiatric disorders and symptoms, ranging from mood dysregulation to delirium, are commonly observed in many neurological disorders. These manifestations complicate the illness and worsen prognosis. Pharmacological treatment options may be limited by the primary neurological illness and side effects. Objective: This paper aims to review the safety and efficacy of pharmacological agents used to treat psychiatric manifestations of several common neurological conditions, including Alzheimer's disease (AD), post-stroke, traumatic brain injury (TBI) and epilepsy. Methods: Systematic review of the Medline database for articles published between 2000 and 2007 was done to retrieve relevant articles. Results: The paucity of controlled data on the pharmacological treatments of psychiatric manifestations of neurological conditions makes recommendations difficult. Conclusion: When secondary depression, mania, anxiety, and delirium remain after treatment of the underlying condition, clinical experience and the limited research indicates that judicious pharmacological interventions may effectively treat mood dysregulation, delirium and agitation.",
keywords = "Aggression, Alzheimer's disease, Antidepressants, Anxiety, Atypical antipsychotics, Benzodiazepines, Carbamazepine, Delirium, Depression, Epilepsy, Mania, Post-stroke, Psychosis, Seizures, Traumatic brain injury, Valproate",
author = "Bernardo, {Carmina G.} and Vivek Singh and Thompson, {Peter M.}",
year = "2008",
month = "7",
doi = "10.1517/14740338.7.4.435",
language = "English (US)",
volume = "7",
pages = "435--445",
journal = "Expert Opinion on Drug Safety",
issn = "1474-0338",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - Safety and efficacy of psychopharmacological agents used to treat the psychiatric sequelae of common neurological disorders

AU - Bernardo, Carmina G.

AU - Singh, Vivek

AU - Thompson, Peter M.

PY - 2008/7

Y1 - 2008/7

N2 - Background: Psychiatric disorders and symptoms, ranging from mood dysregulation to delirium, are commonly observed in many neurological disorders. These manifestations complicate the illness and worsen prognosis. Pharmacological treatment options may be limited by the primary neurological illness and side effects. Objective: This paper aims to review the safety and efficacy of pharmacological agents used to treat psychiatric manifestations of several common neurological conditions, including Alzheimer's disease (AD), post-stroke, traumatic brain injury (TBI) and epilepsy. Methods: Systematic review of the Medline database for articles published between 2000 and 2007 was done to retrieve relevant articles. Results: The paucity of controlled data on the pharmacological treatments of psychiatric manifestations of neurological conditions makes recommendations difficult. Conclusion: When secondary depression, mania, anxiety, and delirium remain after treatment of the underlying condition, clinical experience and the limited research indicates that judicious pharmacological interventions may effectively treat mood dysregulation, delirium and agitation.

AB - Background: Psychiatric disorders and symptoms, ranging from mood dysregulation to delirium, are commonly observed in many neurological disorders. These manifestations complicate the illness and worsen prognosis. Pharmacological treatment options may be limited by the primary neurological illness and side effects. Objective: This paper aims to review the safety and efficacy of pharmacological agents used to treat psychiatric manifestations of several common neurological conditions, including Alzheimer's disease (AD), post-stroke, traumatic brain injury (TBI) and epilepsy. Methods: Systematic review of the Medline database for articles published between 2000 and 2007 was done to retrieve relevant articles. Results: The paucity of controlled data on the pharmacological treatments of psychiatric manifestations of neurological conditions makes recommendations difficult. Conclusion: When secondary depression, mania, anxiety, and delirium remain after treatment of the underlying condition, clinical experience and the limited research indicates that judicious pharmacological interventions may effectively treat mood dysregulation, delirium and agitation.

KW - Aggression

KW - Alzheimer's disease

KW - Antidepressants

KW - Anxiety

KW - Atypical antipsychotics

KW - Benzodiazepines

KW - Carbamazepine

KW - Delirium

KW - Depression

KW - Epilepsy

KW - Mania

KW - Post-stroke

KW - Psychosis

KW - Seizures

KW - Traumatic brain injury

KW - Valproate

UR - http://www.scopus.com/inward/record.url?scp=48749097100&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48749097100&partnerID=8YFLogxK

U2 - 10.1517/14740338.7.4.435

DO - 10.1517/14740338.7.4.435

M3 - Article

C2 - 18613807

AN - SCOPUS:48749097100

VL - 7

SP - 435

EP - 445

JO - Expert Opinion on Drug Safety

JF - Expert Opinion on Drug Safety

SN - 1474-0338

IS - 4

ER -